XML 38 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION PLANS (Details) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended
Jun. 30, 2009
Jun. 30, 2005
Mar. 31, 2013
Stock Options [Member]
Mar. 31, 2012
Stock Options [Member]
Dec. 31, 2012
Stock Options [Member]
Jun. 30, 2012
Stock Options [Member]
Mar. 31, 2013
Stock Options [Member]
Minimum [Member]
Mar. 31, 2013
Stock Options [Member]
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of Common stock shares originally authorized (in shares)   425,000            
Number of Common stock shares authorized under the plan (in shares) 625,000         775,000    
Number of Common Stock approved by the additional amendment (in shares)           150,000    
Shares available for issuance (in shares)     100,868     775,000    
Minimum number of plan administrators     2          
Vested options (in shares)     248,002          
Unvested options (in shares)     210,331          
Fair value assumptions [Abstract]                
Expected life     5 years [1] 5 years [1]        
Risk-free interest rate (in hundredths)     0.88% [2] 0.88% [2]        
Expected volatility (in hundredths)     49.00% [3] 50.00% [3]        
Expected dividend yield (in hundredths)     5.03% 4.79%        
Expected Forfeiture (in hundredths)     17.72% [4] 0.00% [4]        
Options outstanding [Rollforward]                
Outstanding, beginning balance (in shares)     477,767          
Granted (in shares)     15,000          
Exercised (in shares)     (32,834)          
Cancelled (in shares)     (1,600)          
Outstanding, ending balance (in shares)     458,333   477,767      
Exercisable (in shares)     248,002          
Options weighted average exercise price [Roll Forward]                
Outstanding, beginning balance (in dollars per share)     $ 18.63          
Granted (in dollars per share)     $ 17.44          
Exercised (in dollars per share)     $ 17.88          
Cancelled (in dollars per share)     $ 17.75          
Outstanding, ending balance (in dollars per share)     $ 18.65   $ 18.63      
Exercisable (in dollars per share)     $ 18.84          
Range of Exercise Prices [Abstract]                
Outstanding, beginning of period (in dollars per share)             $ 10.75 $ 21.85
Granted (in dollars per share)             $ 17.35 $ 17.50
Exercised (in dollars per share)             $ 10.75 $ 20.02
Cancelled (in dollars per share)             $ 17.75 $ 17.75
Outstanding, end of period (in dollars per share)             $ 10.75 $ 21.85
Exercisable (in dollars per share)             $ 10.75 $ 21.85
Options, additional disclosures [Abstract]                
Outstanding, weighted average remaining contractual term     4 years 3 months 18 days   4 years 3 months 18 days      
Outstanding, aggregate intrinsic value     $ 719,000   $ 223,000      
Exercisable, weighted average remaining contractual term     3 years 4 months 24 days          
Exercisable, aggregate intrinsic value     386,000          
Weighted average grant date fair value of options (in dollars per share)     $ 4.84 $ 5.36        
Net cash proceeds from the exercise of stock options     43,000 0        
Income tax effect     (32,000) 0        
Intrinsic value     146,741 131,545        
Total unrecognized compensation expense     $ 466,000          
Weighted average period for recognition     1 year 8 months 12 days          
[1] The expected life, in years, of stock options is estimated based on historical experience.
[2] The risk-free interest rate is based on U.S. Treasury bills whose term is consistent with the expected life of the stock options.
[3] The expected volatility is estimated based on historical and current stock price data for the Company.
[4] Forfeitures are estimated based on historical experience.